Clinical Trial Update: Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL [Phase 2]

View source ↗

Summary

Phase 2 randomized, double-blind trial evaluating a quadrivalent HPV vaccine to improve responses to LEEP treatment for cervical HSIL (high-grade squamous intra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical High-grade Squamous Intraepithelial Lesion

Drugs mentioned

• quadrivalent HPV vaccine

Snippet

Sponsor: University of Witwatersrand, South Africa | Conditions: Cervical High Grade Squamous Intraepithelial Lesion | Phase 2 | Status: COMPLETED | Results posted: 2020-06-24